Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program.

导出 OA

翻译打印收藏纠错

作者： Kassem S,Faraj ^[1] ; Megan E V,Caram ^[2] ; Vahakn B,Shahinian ^[3] ; Brent K,Hollenbeck ^[1]

作者单位： Dow Division of Health Services Research, Department of Urology, University of Michigan, Ann Arbor, Michigan, USA. ^[1] Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.;VA Health Services Research and Development, Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA. ^[2] Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. ^[3]

关键词 340B drug pricing program cancer treatment financial toxicity safety net specialty drugs

主题词人类(Humans);抗肿瘤药(Antineoplastic Agents);药费支出(Drug Costs);卫生政策(Health Policy);肿瘤(Neoplasms);美国(United States)

DOI 10.1002/cncr.35379

PMID 38804732

发布时间 2024-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交